“…To restore the normal tissue functions during the harmful inflammatory conditions, clearance of inflammatory cells, along with pro-inflammatory signaling pathways, are required ( 1 ). The nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing proteins (NLRPs), specifically NLRP3, a cytosolic innate immune signaling receptor, have been detected at elevated levels in several inflammatory diseases, such as chronic infantile neurological cutaneous and articular (CINCA) syndrome, familial cold auto-inflammatory syndrome (FCAS), keratoendotheliitis fugax hereditaria, Muckle–Wells syndrome (MWS), neonatal onset multisystem inflammatory disease (NOMID) ( 2 , 3 ), and familial Mediterranean fever ( 4 ). In addition, NLRP3 has been associated with gout ( 5 ), type 2 diabetes, multiple sclerosis, atherosclerosis ( 6 ), and Alzheimer's, Parkinson's, and prion diseases ( 7 – 9 ).…”